Univest
Univest
  • Markets

Nifty Pharma Prediction for Tomorrow, 13 August 2026: Defensive Hold Sustains as TCS Crash Keeps Institutional Safe-Haven Allocation Active

  • August 12, 2026
  • Posted by: Kunal Singla
  • Category: Predictions
No Comments
Nifty Pharma Prediction for Tomorrow, 13 August 2026: Defensive Hold Sustains as TCS Crash Keeps Institutional Safe-Haven Allocation Active

Nifty Pharma: Est. 26,800 (flat to +0.3%) (Est. flat to +0.3% Wed 12 Aug). Crude Rs 7,910. BankNifty +0.77%. TCS -3.93%. SBI +1.50%.

The Nifty Pharma prediction for tomorrow for Thursday 13 August 2026 is shaped by Wednesday’s pivotal session on Dalal Street. Nifty 50 closed at 24,435.95 (-0.15%) after testing 24,265.95 intraday and recovering 170 points ; a textbook DII accumulation pattern. Bank Nifty surged to a closing-high of 57,885.85 (+0.77%), SBI posted its Day 4 recovery at +1.50% to Rs 1,082, and TCS crashed 3.93% to Rs 2,349.70 in a sharp IT sector reversal. Most critically for tomorrow, MCX Crude Oil pulled back below Rs 8,000 to Rs 7,910 (-0.38%) on Wednesday ; the first close below Rs 8,000 since Tuesday’s surge ; providing partial relief to crude-sensitive sectors. The Nifty Pharma index is the primary benchmark for this Nifty Pharma prediction for tomorrow and represents the sector covered in this Thursday forecast.

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, present the Nifty Pharma prediction for tomorrow for Thursday using Groww-confirmed Wednesday data. All entry, target and stop-loss levels are observation-based and not guaranteed returns. MCX Gold surged 0.83% to Rs 1,53,859, Silver bounced 1.64% to Rs 2,40,650 and MCX Zinc gained 0.85% to Rs 396.70 ; confirming commodities had a broadly positive Wednesday while equities showed sector rotation.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Wednesday Market Recap for the Nifty Pharma prediction for tomorrow
  • Key Factors for the Nifty Pharma prediction for tomorrow
  • Technical Levels for the Nifty Pharma prediction for tomorrow
  • Stocks to Watch for the Nifty Pharma prediction for tomorrow
  • Strategy for the Nifty Pharma prediction for tomorrow Session
  • Risks to the Nifty Pharma prediction for tomorrow
  • Conclusion
  • FAQs on Nifty Pharma Prediction For Tomorrow, 13 August 2026
    • What is the Nifty Pharma prediction for tomorrow, 13 August 2026?
    • Which analysts prepared the Nifty Pharma prediction for tomorrow?
    • Why does TCS crashing help the Nifty Pharma prediction for tomorrow?
    • What is support and resistance for the Nifty Pharma prediction for tomorrow?
    • Which stocks are watched in the Nifty Pharma prediction for tomorrow?

Wednesday Market Recap for the Nifty Pharma prediction for tomorrow

Indicator Wed 12 Aug (Groww) Change Signal for Nifty Pharma prediction for tomorrow
Nifty 50 24,435.95 -0.15% L: 24,265.95 tested; 170-pt recovery; DII floor confirmed
Bank Nifty 57,885.85 +0.77% Closing-high pattern; SBI +1.50%; ICICI touched Rs 1,435
MCX Crude Rs 7,910/bbl -0.38% Fell below Rs 8,000; partial relief for auto, FMCG, cement
MCX Gold Rs 1,53,859/10g +0.83% Safe-haven demand; near session high Rs 1,53,879
MCX Silver Rs 2,40,650/kg +1.64% Strong bounce; recovering from Tuesday reversal
MCX Zinc Rs 396.70/kg +0.85% Supply deficit; second positive session
MCX Copper Rs 1,384.75/kg +0.41% Industrial demand intact
MCX Nat Gas Rs 266.80/MMBTU +0.53% Consolidating above Rs 265
TCS Rs 2,349.70 -3.93% IT sector reversal; L: Rs 2,300.10; bounce opportunity
SBI Rs 1,082 +1.50% Day 4 booking exhausted; H: Rs 1,085.50
Bharti Airtel Rs 1,945 +1.56% Post-Q1 booking absorbed; ARPU Rs 261 intact
India VIX Est. 13.20-13.80 Rising Below 14 panic threshold; orderly correction

Key Factors for the Nifty Pharma prediction for tomorrow

  • Nifty Pharma +1.02% Tuesday held through Wednesday as defensive rotation sustained. TCS crashing -3.93% Wednesday sustains portfolio-protection allocation to pharma for tomorrow ; when large-cap IT falls 3.93% in a session, institutional managers shift to crude-insensitive defensive growth.
  • Crude Rs 7,910 below Rs 8,000 provides mild energy cost benefit for hospital operators (ambulance fuel, equipment energy) in the Nifty Pharma prediction for tomorrow, while pharmaceutical API manufacturers remain unaffected (crude-insensitive costs).
  • Sun Pharma Rs 1,942 (-0.12% Tuesday) estimated stable Wednesday. for tomorrow, Sun Pharma above Rs 1,952 Thursday = defensive rotation sustaining into Thursday.
  • Conditional moderation: Iran deal confirmed overnight = crude falls sharply = defensive rotation premium unwinds = Nifty Pharma prediction for tomorrow moderates toward flat. Kunal Singla identifies this as primary downside condition for Thursday.

Technical Levels for the Nifty Pharma prediction for tomorrow

Level Zone Significance
Primary Support 26,650-26,720 Confirmed buyer zone from Wednesday’s session
Secondary Support 26,380-26,460 Deeper correction floor if primary breaks
Immediate Resistance 26,950-27,050 First recovery target for Thursday
Key Resistance 27,200-27,350 Extended target if momentum builds

Stocks to Watch for the Nifty Pharma prediction for tomorrow

Stock CMP (Wed) Entry Zone Target Stop Loss Analyst Rationale
Sun Pharma Rs 1,942 (-0.12% Tue) Rs 1,932-1,945 Rs 1,998 Rs 1,895 Ankit Jaiswal Primary Nifty Pharma prediction for tomorrow stock. Defensive rotation sustained from Tuesday +1.02% through Thursday.
Cipla Rs 1,462 approx Rs 1,452-1,465 Rs 1,502 Rs 1,425 Kunal Singla Diversified India-US portfolio breadth for the Nifty Pharma prediction for tomorrow.
Apollo Hospitals Rs 8,750 (Tue close) Rs 8,690-8,755 Rs 8,990 Rs 8,525 Ankit Jaiswal Hospital operator crude cost relief from Rs 7,910. Nifty Pharma prediction for tomorrow hospital component.

Screen All Stocks Live for the Nifty Pharma prediction for tomorrow on Univest Screener

Strategy for the Nifty Pharma prediction for tomorrow Session

  1. Rs 26,650-26,720 primary support for the Nifty Pharma prediction for tomorrow.
  2. Rs 26,950-27,050 first resistance. Sun Pharma above Rs 1,952 Thursday = defensive rotation sustaining.
  3. TCS continuing below Rs 2,280 Thursday = IT weakness extending = Nifty Pharma prediction for tomorrow defensive premium intact.
  4. Kunal Singla: Iran deal overnight = crude sharply lower = Nifty Pharma prediction for tomorrow moderates from +0.3% toward flat.

Risks to the Nifty Pharma prediction for tomorrow

  • Iran deal confirmed overnight removing crude risk and defensive rotation premium in the Nifty Pharma prediction for tomorrow.
  • US FDA warning letters on Indian pharma manufacturing creating sector headwinds in the Nifty Pharma prediction for tomorrow.
  • Sun Pharma below Rs 1,925 Thursday reducing Nifty Pharma prediction for tomorrow primary breadth.

Conclusion

The Nifty Pharma prediction for tomorrow for Thursday 13 August 2026 is shaped by Wednesday’s dominant themes: Bank Nifty’s closing-high (+0.77%), TCS’s sharp reversal (-3.93%), SBI’s Day 4 recovery (+1.50%) and crude oil retreating below Rs 8,000 to Rs 7,910. Ankit Jaiswal of Univest identifies 26,650-26,720 as the primary support and 26,950-27,050 as the immediate resistance for the Nifty Pharma prediction for tomorrow on Thursday. The partial crude relief ; crude below Rs 8,000 for the first time since Tuesday’s surge ; is the most important macro change for crude-sensitive sectors in the Nifty Pharma prediction for tomorrow.

Kunal Singla of Univest recommends using GIFT Nifty above 24,460, ICICI Bank above Rs 1,435 and TCS direction at Thursday’s open as the three pre-market signals that unlock the full Nifty Pharma prediction for tomorrow strategy. Check Brent Crude below USD 92/bbl as confirmation that crude’s Wednesday retreat is sustaining overnight.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Nifty Pharma Prediction For Tomorrow, 13 August 2026

What is the Nifty Pharma prediction for tomorrow, 13 August 2026?

Ans. Flat to mildly positive. Nifty Pharma held +1.02% Tuesday gains through Wednesday. TCS -3.93% sustains defensive rotation into pharma. Crude Rs 7,910 reduces hospital costs. Support 26,650-26,720, resistance 26,950-27,050.

Which analysts prepared the Nifty Pharma prediction for tomorrow?

Ans. Ankit Jaiswal, Senior Research Analyst, and Kunal Singla, Associate Director at Univest, using Groww-confirmed Wednesday data: Bank Nifty +0.77%, TCS -3.93%, crude Rs 7,910.

Why does TCS crashing help the Nifty Pharma prediction for tomorrow?

Ans. TCS -3.93% reduces IT sector portfolio values prompting institutional defensive reallocation. Pharma is crude-insensitive ; IT-to-pharma rotation is the structural driver of the Nifty Pharma prediction for tomorrow positive momentum.

What is support and resistance for the Nifty Pharma prediction for tomorrow?

Ans. Support 26,650-26,720 and 26,380-26,460. Resistance 26,950-27,050 and 27,200-27,350.

Which stocks are watched in the Nifty Pharma prediction for tomorrow?

Ans. Sun Pharma (defensive primary, Rs 1,932-1,945 entry), Cipla (sector breadth) and Apollo Hospitals (crude cost relief).



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply